期刊
AMERICAN JOURNAL OF KIDNEY DISEASES
卷 61, 期 4, 页码 S12-S23出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ajkd.2013.01.005
关键词
Albuminuria; chronic kidney disease; end-stage renal disease; diabetes mellitus; glomerular filtration rate; mortality; nonalbuminuric chronic kidney disease
资金
- National Kidney Foundation Inc
- Abbott
- Amgen
- LifeScan
- Siemens
- Genentech
- GM Foundation
- Nephroceuticals
- Pfizer
- National Cancer Institute, National Institutes of Health (NIH) [KM1CA156708]
- Clinical and Translational Science Award, National Center for Advancing Translational Sciences (NCATS), NIH [UL1 TR000448, KL2 TR000450, TL1 TR000449]
- Department of Veterans Affairs Career Development Award
- American Society of Nephrology-Association of Specialty Professors Development Grant in Geriatric Nephrology
- American Heart Association
- Medtronic Diabetes
- Glumetrics
- Gilead
- NIH [R03AG040638]
Introduction: Chronic kidney disease may complicate diabetes, often manifesting with reduced glomerular filtration rate (GFR), albuminuria, or both. Although greater albuminuria and lower estimated GFR both predict adverse prognosis, whether a synergistic prognostic interaction occurs in patients with diabetes has not been defined in a large national cohort study. Methods: We used 2000-2011 data from the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) for 42,761 participants with diabetes. Kaplan-Meier survival analysis and multivariable Cox regression were used to ascertain the association of estimated GFR, albumin-creatinine ratio (ACR), and their interaction on all-cause mortality and progression to end-stage renal disease (ESRD) at a median 4 years of follow-up. Results: Of 42,761 participants with diabetes, 8,618 (20.2%) had estimated GFR < 60 mL/min/1.73 m(2), 7,715 (18.0%) had ACR > 30 mg/g, and 2,641 (6.2%) had both. The unadjusted incidence (per 1,000 person-years) of all-cause mortality increased from 3.1 (95% CI, 2.4-3.8) in participants with estimated GFR > 105 mL/min/1.73 m(2) and no albuminuria to 73.7 (95% CI, 54.9-92.5) in participants with estimated GFR < 30 mL/min/1.73 m(2) and macroalbuminuria (P < 0.001). Progression to ESRD likewise increased from 0.2 (95% CI, 0-0.4) to 220.4 (95% CI, 177.2-263.6) per 1,000 person-years (P < 0.001). After adjustment for confounders, both estimated GFR and albuminuria were associated independently with mortality and progression to ESRD, with a strong synergistic interaction (P for interaction < 0.001); estimated GFR < 30 mL/min/1.73 m(2) and macroalbuminuria together were associated with a 5-fold higher risk of mortality and a more than 1,000-fold higher risk of progression to ESRD (compared with patients with estimated GFR > 60 mL/min/1.73 m(2) and ACR < 30 mg/g; P < 0.001 for both outcomes). Conclusions: In this large cohort of diabetic KEEP participants with more than 170,000 person-years of follow-up, both estimated GFR and albuminuria were associated independently with mortality and progression to ESRD, with a strong synergistic interaction. Am J Kidney Dis. 61(4)(S2): S12-S23. (C) 2013 by the National Kidney Foundation, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据